Tech & AI
FDA orders vision-loss warning on GLP-1 drug labels
The Food and Drug Administration is requiring makers of GLP-1 receptor agonist drugs to add a new GLP-1 warning on vision loss to their labels. According to Ars Technica, the
Benjamin Scott2 min read
